| Improved prostate cancer biopsy grading by incorporation of invasive cribriform and intraductal carcinoma in the 2014 grade groups GJLH van Leenders, CF Kweldam, E Hollemans, IP Kümmerlin, ... European urology 77 (2), 191-198, 2020 | 73 | 2020 |
| Reduction of MRI-targeted biopsies in men with low-risk prostate cancer on active surveillance by stratifying to PI-RADS and PSA-density, with different thresholds for … IG Schoots, DF Osses, FJH Drost, JFM Verbeek, S Remmers, ... Translational andrology and urology 7 (1), 132, 2018 | 53 | 2018 |
| Multiparametric Ultrasound for Prostate Cancer Detection and Localization: Correlation of B-mode, Shear Wave Elastography and Contrast Enhanced Ultrasound with Radical … CK Mannaerts, RR Wildeboer, S Remmers, RAA van Kollenburg, ... The Journal of urology 202 (6), 1166-1173, 2019 | 51 | 2019 |
| Can active surveillance really reduce the harms of overdiagnosing prostate cancer? A reflection of real life clinical practice in the PRIAS study FJH Drost, A Rannikko, R Valdagni, T Pickles, Y Kakehi, S Remmers, ... Translational Andrology and Urology 7 (1), 98-105, 2018 | 39 | 2018 |
| Results of Prostate Cancer Screening in a Unique Cohort at 19 yr of Follow-up DF Osses, S Remmers, FH Schröder, T van der Kwast, MJ Roobol European urology 75 (3), 374-377, 2019 | 36 | 2019 |
| Europa uomo patient reported outcome study (EUPROMS): descriptive statistics of a prostate cancer survey from patients for patients LDF Venderbos, A Deschamps, J Dowling, EG Carl, S Remmers, ... European Urology Focus 7 (5), 987-994, 2021 | 30 | 2021 |
| Predicting biochemical recurrence and prostate cancer specific mortality after radical prostatectomy: comparison of six prediction models in a cohort of screen and clinically … S Remmers, JFM Verbeek, D Nieboer, T van der Kwast, MJ Roobol BJU international, 2019 | 20 | 2019 |
| Personalized strategies in population screening for prostate cancer S Remmers, MJ Roobol International journal of cancer 147 (11), 2977-2987, 2020 | 19 | 2020 |
| Reducing biopsies and magnetic resonance imaging scans during the diagnostic pathway of prostate cancer: applying the rotterdam prostate cancer risk calculator to the PRECISION … S Remmers, V Kasivisvanathan, JFM Verbeek, CM Moore, MJ Roobol, ... European Urology Open Science 36, 1-8, 2022 | 18 | 2022 |
| A detailed evaluation of the effect of prostate-specific antigen–based screening on morbidity and mortality of prostate cancer: 21-year follow-up results of the Rotterdam … II de Vos, A Meertens, R Hogenhout, S Remmers, MJ Roobol, ... European Urology 84 (4), 426-434, 2023 | 17 | 2023 |
| A multivariable approach using magnetic resonance imaging to avoid a protocol-based prostate biopsy in men on active surveillance for prostate cancer—data from the … HB Luiting, S Remmers, ER Boevé, R Valdagni, PK Chiu, A Semjonow, ... European Urology Oncology 5 (6), 651-658, 2022 | 15 | 2022 |
| NeuroSAFE in radical prostatectomy increases the rate of nerve‐sparing surgery without affecting oncological outcome MA van Der Slot, MA den Bakker, TSC Tan, S Remmers, MB Busstra, ... BJU international 130 (5), 628-636, 2022 | 14 | 2022 |
| A prospective multicenter comparison study of risk-adapted ultrasound-directed and magnetic resonance imaging–directed diagnostic pathways for suspected prostate cancer in … IM Wagensveld, DF Osses, PM Groenendijk, FM Zijta, MB Busstra, ... European Urology 82 (3), 318-326, 2022 | 14 | 2022 |
| Relationship between baseline prostate-specific antigen on cancer detection and prostate cancer death: long-term follow-up from the European Randomized Study of Screening for … S Remmers, CH Bangma, RA Godtman, SV Carlsson, A Auvinen, ... European urology 84 (5), 503-509, 2023 | 11 | 2023 |
| The transition from transrectal to transperineal prostate biopsy without antibiotic prophylaxis: Cancer detection rates and complication rates R Hogenhout, S Remmers, GJLH van Leenders, MJ Roobol Prostate Cancer and Prostatic Diseases 26 (3), 581-587, 2023 | 11 | 2023 |
| Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies LL Rijstenberg, T Hansum, CF Kweldam, IP Kümmerlin, S Remmers, ... Histopathology 80 (7), 1041-1049, 2022 | 11 | 2022 |
| A comparison of prostate cancer prediction models in men undergoing both magnetic resonance imaging and transperineal biopsy: Are the models still relevant? P Doan, P Graham, J Lahoud, S Remmers, MJ Roobol, L Kim, MI Patel BJU international 128, 36-44, 2021 | 11 | 2021 |
| What is the effect of MRI with targeted biopsies on the rate of patients discontinuing active surveillance? A reflection of the use of MRI in the PRIAS study HB Luiting, S Remmers, R Valdagni, ER Boevé, F Staerman, J Rueb, ... Prostate Cancer and Prostatic Diseases 24 (4), 1048-1054, 2021 | 11 | 2021 |
| Comedonecrosis Gleason pattern 5 is associated with worse clinical outcome in operated prostate cancer patients T Hansum, E Hollemans, EI Verhoef, CH Bangma, J Rietbergen, S Osanto, ... Modern Pathology 34 (11), 2064-2070, 2021 | 11 | 2021 |
| Health-related quality of life in Japanese low-risk prostate cancer patients choosing active surveillance: 3-year follow-up from PRIAS-JAPAN H Hirama, M Sugimoto, N Miyatake, T Kato, LDF Venderbos, S Remmers, ... World Journal of Urology 39 (7), 2491-2497, 2021 | 10 | 2021 |
Roobol MJProfessor Decision making in UrologyVerified email at erasmusmc.nl
